Changing physician prescribing habits through a cost-effective first generation cephalosporin formulary
- PMID: 10312858
Changing physician prescribing habits through a cost-effective first generation cephalosporin formulary
Abstract
Cephalosporin antibiotics account for a significant portion (approximately 10%) of our institution's drug budget. A 1985 survey demonstrated that 64% of our first generation injectable cephalosporin (FGIC) orders were for cefazolin. Of the cefazolin orders, approximately 77% used an "every 6 hour" dosage interval. It was thought that this dosage interval was associated with "physician habit" of prescribing similar agents "every 6 hours." By using an "every 8 hour" cefazolin dosage interval in most cases, significant cost savings in the hospital's drug budget could be realized. The Department of Pharmacy and the Pharmacy and Therapeutics (P&T) Committee developed and instituted an FGIC formulary procedure designed to promote the use of cefazolin with an "every 8 hour" dosing interval. Following presentation of literature guidelines to the P&T Committee, measurement of staff physician support through a written survey and presentation of extensive educational programs by the Department of Pharmacy, and FGIC formulary was implemented. The formulary policy included the automatic changing of every 6 hour cefazolin dosing intervals to every 8 hour intervals, with a physician option of "NO SUBSTITUTION." After implementation of the formulary policy, physician prescribing habits for FGIC's changed dramatically. Six months post-formulary, cefazolin accounted for 94% of FGIC prescriptions. Approximately 76% of cefazolin doses were being administered on an "every 8 hour" dosing interval as opposed to 21% prior to formulary implementation. Approximately $45,000 was saved during the first twelve months following formulary implementation. Physicians, pharmacists and nurses have supported the formulary policy.
Similar articles
-
Savings achieved through cephalosporin surveillance.Am J Hosp Pharm. 1978 Dec;35(12):1521-3. Am J Hosp Pharm. 1978. PMID: 717407
-
Cost savings achieved through cephalosporin use review and restriction.Am J Hosp Pharm. 1986 Sep;43(9):2194-7. Am J Hosp Pharm. 1986. PMID: 3766571
-
Controlling financial variables--changing prescribing patterns.Am J Hosp Pharm. 1984 Mar;41(3):503-15. Am J Hosp Pharm. 1984. PMID: 6367444 Review.
-
Controlling cephalosporin and aminoglycoside costs through pharmacy and therapeutics committee restrictions.Am J Hosp Pharm. 1985 Jun;42(6):1343-7. Am J Hosp Pharm. 1985. PMID: 4014250
-
Enhancing the role of physicians in the cost-effective use of pharmaceuticals.Hosp Formul. 1994 Apr;29(4):262-6, 273. Hosp Formul. 1994. PMID: 10133126 Review.
Cited by
-
Pharmacoeconomic consequences of measurement and modification of hospital drug use.Pharmacoeconomics. 1992 Jul;2(1):15-33. doi: 10.2165/00019053-199202010-00004. Pharmacoeconomics. 1992. PMID: 10146976 Review.
-
Cephalosporin utilisation review and evaluation.Pharmacoeconomics. 1995 Aug;8(2):100-22. doi: 10.2165/00019053-199508020-00003. Pharmacoeconomics. 1995. PMID: 10155606 Review.